标题
Bedaquiline and delamanid in tuberculosis
作者
关键词
-
出版物
EXPERT OPINION ON PHARMACOTHERAPY
Volume 16, Issue 15, Pages 2319-2330
出版商
Informa Healthcare
发表日期
2015-09-21
DOI
10.1517/14656566.2015.1080240
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bactericidal Activity of Pyrazinamide and Clofazimine Alone and in Combinations with Pretomanid and Bedaquiline
- (2015) Andreas H. Diacon et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis
- (2015) Rodney Dawson et al. LANCET
- Facing multi-drug resistant tuberculosis
- (2015) Giovanni Sotgiu et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Bedaquiline
- (2014) Elias B. Chahine et al. ANNALS OF PHARMACOTHERAPY
- Cross-Resistance between Clofazimine and Bedaquiline through Upregulation of MmpL5 in Mycobacterium tuberculosis
- (2014) R. C. Hartkoorn et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel Regimens Identified in Mice for Treatment of Latent Tuberculosis Infection in Contacts of Patients with Multidrug-Resistant Tuberculosis
- (2014) Jean-Philippe Lanoix et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Delamanid Does Not Inhibit or Induce Cytochrome P450 Enzymes in Vitro
- (2014) Yoshihiko Shimokawa et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Tuberculosis
- (2014) Yong-Soo Kwon et al. CURRENT OPINION IN PULMONARY MEDICINE
- Delamanid: A Review of Its Use in Patients with Multidrug-Resistant Tuberculosis
- (2014) Hannah A. Blair et al. DRUGS
- Delamanid: First Global Approval
- (2014) Nicola J. Ryan et al. DRUGS
- ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid use
- (2014) S. Esposito et al. EUROPEAN RESPIRATORY JOURNAL
- Novel drugs against tuberculosis: a clinician's perspective
- (2014) Ioana Diana Olaru et al. EUROPEAN RESPIRATORY JOURNAL
- Drug resistance among tuberculosis cases in the European Union and European Economic Area, 2007 to 2012
- (2014) M J van der Werf et al. Eurosurveillance
- The early bactericidal activity of antituberculosis drugs
- (2014) Andreas H Diacon et al. Expert Review of Anti-Infective Therapy
- Totally drug-resistant tuberculosis and adjunct therapies
- (2014) S. K. Parida et al. JOURNAL OF INTERNAL MEDICINE
- New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects
- (2014) Alimuddin I Zumla et al. LANCET INFECTIOUS DISEASES
- FDA Approval of Bedaquiline — The Benefit–Risk Balance for Drug-Resistant Tuberculosis
- (2014) Edward Cox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline
- (2014) Andreas H. Diacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bedaquiline: A Novel Antitubercular Agent for the Treatment of Multidrug-Resistant Tuberculosis
- (2014) Marylee V. Worley et al. PHARMACOTHERAPY
- A Mycobacterium tuberculosis Cytochrome bd Oxidase Mutant Is Hypersensitive to Bedaquiline
- (2014) M. Berney et al. mBio
- Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism
- (2014) Anil Koul et al. Nature Communications
- Extensively drug-resistant tuberculosis: epidemiology and management
- (2014) Alberto Matteelli et al. Clinical Epidemiology
- Randomized Dose-Ranging Study of the 14-Day Early Bactericidal Activity of Bedaquiline (TMC207) in Patients with Sputum Microscopy Smear-Positive Pulmonary Tuberculosis
- (2013) Andreas H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efflux Inhibition with Verapamil Potentiates Bedaquiline in Mycobacterium tuberculosis
- (2013) Shashank Gupta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Model-Based Estimates of the Effects of Efavirenz on Bedaquiline Pharmacokinetics and Suggested Dose Adjustments for Patients Coinfected with HIV and Tuberculosis
- (2013) Elin M. Svensson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Benefit of Delamanid (OPC-67683) in the Treatment of Multidrug-Resistant Tuberculosis Patients in China
- (2013) Qing Zhang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Drug-resistant tuberculosis
- (2013) Emanuele Pontali et al. CURRENT OPINION IN PULMONARY MEDICINE
- An Update on the Chemistry and Medicinal Chemistry of Novel Antimycobacterial Compounds
- (2013) Frederico Branco et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Extensively drug-resistant tuberculosis: early access to bedaquiline for a UK patient
- (2013) C. van Halsema et al. EUROPEAN RESPIRATORY JOURNAL
- Bedaquiline in MDR/XDR-TB cases: first experience on compassionate use
- (2013) S. Tiberi et al. EUROPEAN RESPIRATORY JOURNAL
- Bedaquiline: A new drug approved for treatment of multidrug-resistant tuberculosis
- (2013) Shashank Deoghare INDIAN JOURNAL OF PHARMACOLOGY
- Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis
- (2013) M. McGrath et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Drug-resistant tuberculosis: time for visionary political leadership
- (2013) Ibrahim Abubakar et al. LANCET INFECTIOUS DISEASES
- Rising to the challenge: new therapies for tuberculosis
- (2013) Emily B. Wong et al. TRENDS IN MICROBIOLOGY
- Pipeline of drugs for related diseases
- (2013) Kelly E. Dooley et al. Current Opinion in HIV and AIDS
- Consensus Statement on Research Definitions for Drug-Resistant Tuberculosis in Children
- (2013) J. A. Seddon et al. Journal of the Pediatric Infectious Diseases Society
- Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance
- (2012) A. H. Diacon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- New Mutations in the Mycobacterial ATP Synthase: New Insights into the Binding of the Diarylquinoline TMC207 to the ATP Synthase C-Ring Structure
- (2012) Elena Segala et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tuberculosis: The drug development pipeline at a glance
- (2012) Baptiste Villemagne et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes
- (2012) Dennis Falzon et al. EUROPEAN RESPIRATORY JOURNAL
- Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis
- (2012) Vija Skripconoka et al. EUROPEAN RESPIRATORY JOURNAL
- New drugs for the treatment of tuberculosis: hope and reality [State of the Art Series. New tools. Number 2 in the series]
- (2012) J. H. Grosset et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
- (2012) Maria Tarcela Gler et al. NEW ENGLAND JOURNAL OF MEDICINE
- New treatment options for multidrug-resistant tuberculosis
- (2012) Stephen K. Field et al. Therapeutic Advances in Respiratory Disease
- Pharmacokinetics and Pharmacodynamics of TMC207 and ItsN-Desmethyl Metabolite in a Murine Model of Tuberculosis
- (2011) Marie-Claude Rouan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Totally Drug-Resistant Tuberculosis in India
- (2011) Z. F. Udwadia et al. CLINICAL INFECTIOUS DISEASES
- Nitroimidazoles for the treatment of TB: past, present and future
- (2011) Tathagata Mukherjee et al. Future Medicinal Chemistry
- Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients
- (2011) A. H. Diacon et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Safety, Tolerability, and Pharmacokinetic Interactions of the Antituberculous Agent TMC207 (Bedaquiline) With Efavirenz in Healthy Volunteers
- (2011) Kelly E. Dooley et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Sterilizing Activity of Second-Line Regimens Containing TMC207 in a Murine Model of Tuberculosis
- (2011) Nicolas Veziris et al. PLoS One
- Probing the Interaction of the Diarylquinoline TMC207 with Its Target Mycobacterial ATP Synthase
- (2011) Anna C. Haagsma et al. PLoS One
- Rip Van Winkle Wakes Up: Development of Tuberculosis Treatment in the 21st Century
- (2010) William J. Burman CLINICAL INFECTIOUS DISEASES
- Drugs in Development for Tuberculosis
- (2010) Ann M. Ginsberg DRUGS
- New drugs and regimens for treatment of TB
- (2010) Eric Leibert et al. Expert Review of Anti-Infective Therapy
- Current development and future prospects in chemotherapy of tuberculosis
- (2010) Eric L. NUERMBERGER et al. RESPIROLOGY
- Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis
- (2009) Evan W Orenstein et al. LANCET INFECTIOUS DISEASES
- Unorthodox Approach to the Development of a New Antituberculosis Therapy
- (2009) Clifton E. Barry NEW ENGLAND JOURNAL OF MEDICINE
- The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
- (2009) Andreas H. Diacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary Tuberculosis
- (2008) R. Rustomjee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- OPC-67683
- (2008) TUBERCULOSIS
- The early bactericidal activity of anti-tuberculosis drugs: a literature review
- (2008) P.R. Donald et al. TUBERCULOSIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search